| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 9
| Issue : 1 | Page : 33-37 |
|
|
COVID immunity in the Angolan population: Serological study with Abbott COVID-19 IgG/IgM Rapid Test and serological mini VIDAS BIOMERIEUX test
Renata Almeida1, Ileana Desormais2, Philippe Taton3, Elvis Morales4, Andre Reis4, Yara Simba4
1 International SOS Talatona Clinic, Luanda, Angola
2 National Institute for Health and Medical Research (INSERM), University of Limoges, CHU Limoges, IRD, U 1094, GEIST, Limoges, France
3 CMS Total, Luanda, Angola
4 Paz Flor Medical Center, Luanda, Angola
Correspondence Address:
Dr. Renata Almeida
International SOS Talatona Clinic, OfficeRua S10 Sector Talatona, Zona CC-B2, Luanda.
Angola
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/mgmj.mgmj_91_21
|
|
|
Background: The numbers of severe COVID cases and COVID-related deaths on the African continent are lower than expected. We hypothesize that this paradox may be due to the achieved immunity in black Africans. Materials and Methods: A prospective study was conducted on Angolan people who performed the Panbio Abbott COVID-19 IgG/IgM Rapid Test in a health unit in Luanda. One hundred randomly selected subjects in those with positive immunoglobulin G (IgG) underwent the serological mini VIDAS BIOMERIEUX test. Results: In our population study (2409 subjects), 791 (32.83%) had positive IgG at the Panbio Abbott COVID-19 test. One hundred were randomly selected. The mean age was 39.55, and 96% were males. The positivity to IgG was validated in 72 subjects at the mini VIDAS BIOMERIEUX test. Conclusion: These results support our hypothesis that in the Angolan/African population a previously achieved immunity may be one of the reasons why this continent was not affected by COVID-19 as expected. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
